Malaysia pushes WHO on collective drug purchasing to ease supply shortages

KUALA LUMPUR — Malaysian health authorities have called for a coordinated approach to pharmaceutical purchasing within the WHO Western Pacific Region, arguing that collective procurement would strengthen supply security and reduce costs for member states.

The proposal comes as countries across South and Southeast Asia grapple with medicine shortages and price volatility exacerbated by global supply chain disruptions. By consolidating purchasing power through WHO-led mechanisms, regional nations could negotiate better terms with suppliers and ensure more stable access to essential medications, Malaysian officials contend.

The initiative reflects broader concerns among regional governments about pharmaceutical security in the post-pandemic environment. Supply interruptions during the COVID-19 crisis exposed vulnerabilities in individual nation-based procurement strategies, prompting renewed focus on multilateral solutions.

If adopted, the pooled purchasing model would allow participating nations to share information on drug availability, coordinate orders, and collectively address pricing pressures. The approach has precedent in other multilateral health initiatives and could serve as a template for addressing shared vulnerabilities across the region.

The proposal is expected to be discussed among WPRO member states at upcoming regional health forums, where officials will consider implementation frameworks and governance structures for any collective procurement system.